SKBA Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,446
Closed -$648K 77
2018
Q3
$648K Sell
10,446
-228,019
-96% -$13.9M 0.08% 53
2018
Q2
$12.8M Sell
238,465
-5,217
-2% -$261K 1.73% 29
2018
Q1
$11.1M Buy
+243,682
New +$10.4M 1.5% 32
2017
Q4
Sell
-266,057
Closed -$9.81M 77
2017
Q3
$9.81M Sell
266,057
-628
-0.2% -$22.4K 1.41% 38
2017
Q2
$10.3M Sell
266,685
-202,025
-43% -$7.4M 1.55% 32
2017
Q1
$16M Sell
468,710
-58,828
-11% -$1.93M 2.12% 18
2016
Q4
$17.3M Sell
527,538
-27,528
-5% -$893K 2.04% 22
2016
Q3
$17.9M Sell
555,066
-98,800
-15% -$3.2M 2% 24
2016
Q2
$20.2M Buy
653,866
+272,894
+72% +$8.54M 1.97% 23
2016
Q1
$11.4M Buy
380,972
+372,299
+4,293% +$10.3M 1.15% 45
2015
Q4
$240K Buy
+8,673
New +$247K 0.02% 83

Other funds holding EHC

SKBA Capital Management's EHC Position: Q4 2018 in Review

SKBA Capital Management sold out of Encompass Health (EHC) in Q4 2018, closing a stake of 10,446 shares — an estimated $648K sold.

SKBA Capital Management first reported a position in EHC in Q4 2015 and held it in 11 quarters. The position peaked at $20.2M in Q2 2016. 447 funds tracked by Wall St. Rank hold EHC as of Q4 2018.

  • SKBA Capital Management reported no remaining Encompass Health position as of Q4 2018 after selling out during the quarter.
  • SKBA Capital Management sold 10,446 Encompass Health shares in Q4 2018, an estimated $648K.
  • SKBA Capital Management first reported a position in Encompass Health in Q4 2015 and held it in 11 quarters.
  • SKBA Capital Management's Encompass Health position peaked at $20.2M in Q2 2016.
  • 447 funds tracked by Wall St. Rank held Encompass Health as of Q4 2018.

Based on SKBA Capital Management's 13F filing for Q4 2018, filed 7 Feb 2019.